Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Diseases of the Cardiovascular System
What is the purpose of this trial?
Prospective, randomized, open-label, international, multi-center clinical study to evaluate the safety and efficacy of the AccuCinch Ventricular Restoration System in patients with heart failure and reduced ejection fraction (HFrEF).
- Ages18 years and older
- Trial withAncora Heart, Inc.
- Start Date04/30/2021
- End Date01/27/2025
- Last Updated11/17/2021
- Study HIC#2000028335